These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 24020521

  • 1. Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model.
    Wilson AJ, Barham W, Saskowski J, Tikhomirov O, Chen L, Lee HJ, Yull F, Khabele D.
    J Ovarian Res; 2013 Sep 10; 6(1):63. PubMed ID: 24020521
    [Abstract] [Full Text] [Related]

  • 2. Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer.
    Wilson AJ, Saskowski J, Barham W, Khabele D, Yull F.
    Mol Cancer; 2015 Nov 09; 14():192. PubMed ID: 26552746
    [Abstract] [Full Text] [Related]

  • 3. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
    Wilson AJ, Saskowski J, Barham W, Yull F, Khabele D.
    J Ovarian Res; 2015 Jul 28; 8():46. PubMed ID: 26215403
    [Abstract] [Full Text] [Related]

  • 4. Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer.
    Hoover AA, Hufnagel DH, Harris W, Bullock K, Glass EB, Liu E, Barham W, Crispens MA, Khabele D, Giorgio TD, Wilson AJ, Yull FE.
    BMC Cancer; 2020 Oct 07; 20(1):970. PubMed ID: 33028251
    [Abstract] [Full Text] [Related]

  • 5. Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer.
    Glass EB, Hoover AA, Bullock KK, Madden MZ, Reinfeld BI, Harris W, Parker D, Hufnagel DH, Crispens MA, Khabele D, Rathmell WK, Rathmell JC, Wilson AJ, Giorgio TD, Yull FE.
    BMC Cancer; 2022 May 06; 22(1):497. PubMed ID: 35513776
    [Abstract] [Full Text] [Related]

  • 6. Polyphyllin I Ameliorates Collagen-Induced Arthritis by Suppressing the Inflammation Response in Macrophages Through the NF-κB Pathway.
    Wang Q, Zhou X, Zhao Y, Xiao J, Lu Y, Shi Q, Wang Y, Wang H, Liang Q.
    Front Immunol; 2018 May 06; 9():2091. PubMed ID: 30319603
    [Abstract] [Full Text] [Related]

  • 7. Role of M2-like macrophages in the progression of ovarian cancer.
    Baek SH, Lee HW, Gangadaran P, Oh JM, Zhu L, Rajendran RL, Lee J, Ahn BC.
    Exp Cell Res; 2020 Oct 15; 395(2):112211. PubMed ID: 32755554
    [Abstract] [Full Text] [Related]

  • 8. Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
    Yoshida M, Taguchi A, Kawana K, Adachi K, Kawata A, Ogishima J, Nakamura H, Fujimoto A, Sato M, Inoue T, Nishida H, Furuya H, Tomio K, Arimoto T, Koga K, Wada-Hiraike O, Oda K, Nagamatsu T, Kiyono T, Osuga Y, Fujii T.
    PLoS One; 2016 Oct 15; 11(8):e0160330. PubMed ID: 27483433
    [Abstract] [Full Text] [Related]

  • 9. Development of a syngeneic mouse model of epithelial ovarian cancer.
    Quinn BA, Xiao F, Bickel L, Martin L, Hua X, Klein-Szanto A, Connolly DC.
    J Ovarian Res; 2010 Oct 19; 3():24. PubMed ID: 20958993
    [Abstract] [Full Text] [Related]

  • 10. NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.
    Ignacio RM, Kabir SM, Lee ES, Adunyah SE, Son DS.
    PLoS One; 2016 Oct 19; 11(10):e0164189. PubMed ID: 27723802
    [Abstract] [Full Text] [Related]

  • 11. Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation.
    Cho U, Kim B, Kim S, Han Y, Song YS.
    Mol Carcinog; 2018 Feb 19; 57(2):235-242. PubMed ID: 29024042
    [Abstract] [Full Text] [Related]

  • 12. PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression.
    Prat M, Coulson K, Blot C, Jacquemin G, Romano M, Renoud ML, AlaEddine M, Le Naour A, Authier H, Rahabi MC, Benmoussa K, Salon M, Parny M, Delord JP, Ferron G, Lefèvre L, Couderc B, Coste A.
    J Immunother Cancer; 2023 Aug 19; 11(8):. PubMed ID: 37586764
    [Abstract] [Full Text] [Related]

  • 13. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
    Inoue S, Ide H, Mizushima T, Jiang G, Netto GJ, Gotoh M, Miyamoto H.
    Mol Cancer Ther; 2018 Jun 19; 17(6):1303-1314. PubMed ID: 29592878
    [Abstract] [Full Text] [Related]

  • 14. CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer.
    K Au K, Peterson N, Truesdell P, Reid-Schachter G, Khalaj K, Ren R, Francis JA, Graham CH, Craig AW, Koti M.
    Gynecol Oncol; 2017 Jun 19; 145(3):436-445. PubMed ID: 28318643
    [Abstract] [Full Text] [Related]

  • 15. In vitro evaluation of inhibitory effect of nuclear factor-kappaB activity by small interfering RNA on pro-tumor characteristics of M2-like macrophages.
    Kono Y, Kawakami S, Higuchi Y, Yamashita F, Hashida M.
    Biol Pharm Bull; 2014 Jun 19; 37(1):137-44. PubMed ID: 24141263
    [Abstract] [Full Text] [Related]

  • 16. Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
    Baert T, Vankerckhoven A, Riva M, Van Hoylandt A, Thirion G, Holger G, Mathivet T, Vergote I, Coosemans A.
    Front Immunol; 2019 Jun 19; 10():1273. PubMed ID: 31214202
    [Abstract] [Full Text] [Related]

  • 17. LincRNA-p21 promotes classical macrophage activation in acute respiratory distress syndrome by activating NF-κB.
    Zhang XY, Chen ZC, Zhang LX, Li XS, Guo YL, Tian CJ, Cheng DJ, Tang XY.
    Exp Lung Res; 2020 Jun 19; 46(6):174-184. PubMed ID: 32362153
    [Abstract] [Full Text] [Related]

  • 18. Imaging of Tumor-Associated Macrophages in a Transgenic Mouse Model of Orthotopic Ovarian Cancer.
    He H, Chiu AC, Kanada M, Schaar BT, Krishnan V, Contag CH, Dorigo O.
    Mol Imaging Biol; 2017 Oct 19; 19(5):694-702. PubMed ID: 28233218
    [Abstract] [Full Text] [Related]

  • 19. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.
    He S, Niu G, Shang J, Deng Y, Wan Z, Zhang C, You Z, Shen H.
    J Exp Clin Cancer Res; 2017 Oct 04; 36(1):137. PubMed ID: 28978336
    [Abstract] [Full Text] [Related]

  • 20. Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.
    Tang X, Wang X, Zhao YY, Curtis JM, Brindley DN.
    Mol Cancer; 2017 Feb 08; 16(1):36. PubMed ID: 28178994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.